In prostate adenocarcinoma, the androgen receptor (AR) is a hormone-responsive nuclear receptor transcription factor that coordinates anabolic processes to enable tumor proliferation through transcriptional regulation of metabolic pathways [32]. This evidence concerns the gene AR and prostate adenocarcinoma.